Stockreport

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders [Yahoo! Finance]

Addex Therapeutics Ltd - American Depositary Shares  (ADXN) 
PDF Addex contributes portfolio of preclinical neuroscience assets and allosteric modulator small molecule discovery technology platform to Neurosterix Ad Hoc Announcemen [Read more]